Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)

NCT04589949 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04589949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04589949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)
Lead sponsor
Erasmus Medical Center
Phase
Phase 3
Overall status
Terminated
Start date
October 12, 2020
Completion date
March 1, 2022
Enrollment
420 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

covid19